A 52-year-old man with community-acquired pneumonia is admitted to the ICU. Blood cultures grow Streptococcus pneumoniae. On day 3, despite appropriate antibiotics and fluid resuscitation, he develops hypotension requiring noradrenaline infusion. Which single clinical feature best distinguishes septic shock from severe sepsis in this patient?

Explanation

## Distinguishing Septic Shock from Severe Sepsis ### Definitions and Key Differences **Key Point:** Septic shock is defined as sepsis WITH persistent hypotension requiring vasopressor therapy to maintain MAP ≥65 mmHg DESPITE adequate fluid resuscitation, plus evidence of tissue hypoperfusion (elevated lactate, altered mental status). **High-Yield:** The critical discriminator between severe sepsis and septic shock is the **requirement for vasopressor support** due to refractory hypotension. Severe sepsis lacks this vasopressor-dependent hypotension. ### Comparison Table | Feature | Severe Sepsis | Septic Shock | |---------|---------------|---------------| | Infection + SIRS | Present | Present | | Hypotension | May occur, responds to fluids | Persistent, requires vasopressors | | Vasopressor requirement | Not needed | **Required** | | Tissue hypoperfusion markers | May be absent | Present (lactate, altered mental status) | | Mortality | ~15–20% | ~40–50% | ### Clinical Pearl The 2016 Surviving Sepsis Campaign guidelines emphasize that septic shock represents a subset of sepsis in which underlying circulatory, cellular, and metabolic abnormalities are profound enough to substantially increase mortality risk beyond that of sepsis alone. The need for vasopressor therapy is the operational threshold that separates these two entities. ### Why This Matters Recognizing the transition from severe sepsis to septic shock triggers escalation of care intensity, inclusion in septic shock protocols, and more aggressive monitoring of tissue perfusion endpoints (lactate clearance, ScvO₂). [cite:Harrison 21e Ch 297]